Microbiology
Showing page 62 of 248 pages of list content
-
Potential antiviral options against SARS-CoV-2 infection
This article's authors -
Performance of Abbott ID NOW COVID-19 rapid nucleic acid amplification test in nasopharyngeal swabs transported in viral media and dry nasal swabs, in a New York City academic institution
This article's authors -
Comparative analysis of antiviral efficacy of FDA-approved drugs against SARS-CoV-2 in human lung cells: Nafamostat is the most potent antiviral drug candidate
This article's authors -
Clinical performance of SARS-CoV-2 IgG antibody tests and potential protective immunity
This article's authors -
Multiple introductions, regional spread and local differentiation during the first week of COVID-19 epidemic in Montevideo, Uruguay
This article's authors -
SARS-CoV-2 Spike Glycoprotein and ACE2 interaction reveals modulation of viral entry in wild and domestic animals
This article's authors -
Efficacy of a novel iodine complex solution, CupriDyne, in inactivating SARS-CoV-2
This article's authors -
Suramin inhibits SARS-CoV-2 infection in cell culture by interfering with early steps of the replication cycle
This article's authors -
The coding capacity of SARS-CoV-2
This article's authors -
A Combined approach of MALDI-TOF Mass Spectrometry and multivariate analysis as a potential tool for the detection of SARS-CoV-2 virus in nasopharyngeal swabs
This article's authors